...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith related comments from GAC's Bloom Burton Experience

Toinv....as mentioned, I do not own any Zenith so I was not "zeroed in" so to speak.  He talked about trial results, it might have been my assumption that there is more than one....

My "impression"....and this is just what I thought, is that if a buyout is coming...the way Don talked it struck me that he was talking about the whole enchillada.  

Share
New Message
Please login to post a reply